PPT3- COST-EFFECTIVENESS OF TRANSFUSING PLATELET COMPONENTS PREPARED WITH PATHOGEN INACTIVATION TREATMENT IN ORTHOPEDIC SURGERY IN THE UNITED STATES
Abstract
Authors
X Gao MF Botteman JL Weissfeld CL Pashos D Triulzi U Staginnus